Adaptimmune Therapeutics plc (NASDAQ: ADAP) has announced that the U.S. FDA has granted accelerated approval for TECELRA® (afamitresgene autoleucel) as the first engineered cell therapy for treating solid tumors. This approval is specifically for adults with unresectable or metastatic synovial…
VSee Health, Inc. (Nasdaq: VSEE), known for its telehealth services that optimize workflows and improve patient care, has partnered with Ava Robotics, a leader in intelligent workplace robots. Together, they will develop telepresence solutions for the inpatient ICU market, including…
Eric Swaim, VP of Strategic Sourcing at HealthTrust Performance Group, has received Healthcare Purchasing News’ inaugural 40 Under 40 award. This honor highlights outstanding professionals in healthcare who are significantly impacting their organizations. HealthTrust Performance Group, a leader in healthcare…
Desktop Health, a leading brand in production-grade medical 3D printing from Desktop Metal, Inc. (NYSE: DM), has validated its Flexcera® Smile Ultra+ resin for use in dental implantology, specifically for All-on-X implant provisionals. Flexcera Smile Ultra+ is already FDA (510)k…
Medidata, a Dassault Systèmes company and a leading provider of clinical trial solutions, has announced that Eisai Incorporated, the U.S. subsidiary of Tokyo-based Eisai Co., Ltd., is among the first to implement the new Medidata Clinical Data Studio. This advanced…
Novaliq, a biopharmaceutical company specializing in innovative ocular therapies using EyeSol® waterless technology, has announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Vevizye®. This product is aimed at…
Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), a frontrunner in AI-driven cardiovascular medicine, has unveiled its newly redesigned website, CDIO.AI. This upgraded platform underscores the Company’s commitment to an AI-first approach and showcases its advanced, scalable solutions for preventing, detecting, and…
Hologic, Inc. (Nasdaq: HOLX) has announced its financial results for the fiscal third quarter ending June 29, 2024. “We delivered another strong financial performance in Q3 2024, marked by sequential improvements in our operating margin and robust cash flow,” said…
NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) has announced the successful closing of its underwritten public offering, which included common stock, pre-funded warrants, and Series F-1, F-2, and F-3 warrants, raising approximately $3.87 million before underwriting discounts and expenses. This total…
Battelle, renowned for its extensive expertise in research, laboratory analysis, and consulting on Per- and Polyfluoroalkyl Substances (PFAS), is now leveraging its skills in response to the growing awareness and regulation of these chemicals. With increasing federal regulations like the…
Tandem Diabetes Care and Dexcom Announce Compatibility of t:slim X2 Insulin Pump with Dexcom G7 CGM in Canada Tandem Diabetes Care, Inc. (Nasdaq: TNDM) and Dexcom, Inc. (Nasdaq: DXCM) have announced that the updated software for the t:slim X2™ insulin…
Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) announced today that it has received New Drug Application (NDA) approval from the U.S. Food and Drug Administration (FDA) for its new potassium phosphates in 0.9% sodium chloride IV bags. This new ready-to-use (RTU) sterile…